IDDF2024-ABS-0117 Long-term outcomes of different treatment strategies in T1 colorectal cancer patients

<h3>Background</h3> The treatment strategies for T1 colorectal cancer (CRC) remain controversial. We aimed to investigate the long-term outcomes of the different treatments and evaluate the risk factors for the prognosis. <h3>Methods</h3> We enrolled patients with T1 CRC between February 2010 and August 2021. The patients were divided into 4 groups based on their treatment: Group A, endoscopic resection; Group B, endoscopic or transanal local resection with additional radical resection; Group C, transanal local resection; Group D, radical resection. Their medical histories were retrospectively reviewed, and follow-up results were obtained by medical histories or telephone calls. <h3>Results</h3> 1034 patients were finally chosen for analysis, whose mean age was 58.6±11.7 years old. The number of patients was 121, 200, 99, and 614 in each group, respectively. With a median follow-up of 49 months, 56 patients had recurrence (5.42%). The 5-year recurrence-free (RFS) survival rates in each group were 92.2%, 98.0%, 79.8%, and 93.2% (P&lt;0.001), respectively. The 5-year overall survival (OS) rates in each group were 88.8%, 94.7%, 84.9%, and 95.1%, respectively (P=0.051). The differences in RFS and OS mainly lay in the patients with risk factors based on Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines. Multivariate analyses identified tumor size≥ 2 cm (HR 1.911; 95% CI 1.019–3.583), rectal cancer (HR 2.129; 95% CI 1.158–3.915), lymphovascular invasion (HR 2.954; 95% CI 1.328–6.573), and tumor histologic grade (HR 3.199; 95% CI 1.565–6.538) as independent predictive factors of RFS, and rectal cancer (HR 2.107; 95% CI 1.165–3.810), lymphovascular invasion (HR 3.041; 95% CI 1.290–7.166), and age group (HR 5.185; 95% CI 1.619–16.610) as an independent predictive factor of OS. <h3>Conclusions</h3> The long-term outcomes of local resection are comparable to those of surgery in patients without high-risk factors, while for those with high-risk factors transanal local resection showed poorer RFS and OS when compared with other groups. Tumor size≥ 2 cm, rectal cancer, lymphovascular invasion, tumor histologic grade, and age group may be important long-term prognostic factors for T1 CRC patients.

Authors

Institutions

Publication Details

Journal
Clinical Gastroenterology
Published
2024-08-01
DOI
https://doi.org/10.1136/gutjnl-2024-iddf.261
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IDDF2024-ABS-0117 Long-term outcomes of different treatment strategies in T1 colorectal cancer patients

Yi Lü, Jiachen Sun
Clinical Gastroenterology
Multiple and Secondary Primary Cancers
article

IDDF2024-ABS-0117 Long-term outcomes of different treatment strategies in T1 colorectal cancer patients

Yi Lü, Jiachen Sun
article en

Abstract

<h3>Background</h3> The treatment strategies for T1 colorectal cancer (CRC) remain controversial. We aimed to investigate the long-term outcomes of the different treatments and evaluate the risk factors for the prognosis. <h3>Methods</h3> We enrolled patients with T1 CRC between February 2010 and August 2021. The patients were divided into 4 groups based on their treatment: Group A, endoscopic resection; Group B, endoscopic or transanal local resection with additional radical resection; Group C, transanal local resection; Group D, radical resection. Their medical histories were retrospectively reviewed, and follow-up results were obtained by medical histories or telephone calls. <h3>Results</h3> 1034 patients were finally chosen for analysis, whose mean age was 58.6±11.7 years old. The number of patients was 121, 200, 99, and 614 in each group, respectively. With a median follow-up of 49 months, 56 patients had recurrence (5.42%). The 5-year recurrence-free (RFS) survival rates in each group were 92.2%, 98.0%, 79.8%, and 93.2% (P&lt;0.001), respectively. The 5-year overall survival (OS) rates in each group were 88.8%, 94.7%, 84.9%, and 95.1%, respectively (P=0.051). The differences in RFS and OS mainly lay in the patients with risk factors based on Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines. Multivariate analyses identified tumor size≥ 2 cm (HR 1.911; 95% CI 1.019–3.583), rectal cancer (HR 2.129; 95% CI 1.158–3.915), lymphovascular invasion (HR 2.954; 95% CI 1.328–6.573), and tumor histologic grade (HR 3.199; 95% CI 1.565–6.538) as independent predictive factors of RFS, and rectal cancer (HR 2.107; 95% CI 1.165–3.810), lymphovascular invasion (HR 3.041; 95% CI 1.290–7.166), and age group (HR 5.185; 95% CI 1.619–16.610) as an independent predictive factor of OS. <h3>Conclusions</h3> The long-term outcomes of local resection are comparable to those of surgery in patients without high-risk factors, while for those with high-risk factors transanal local resection showed poorer RFS and OS when compared with other groups. Tumor size≥ 2 cm, rectal cancer, lymphovascular invasion, tumor histologic grade, and age group may be important long-term prognostic factors for T1 CRC patients.

Clinical Gastroenterology
Sun Yat-sen University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN)
Good health and well-being
Openalex Percentile: Top 43%
Multiple and Secondary Primary Cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.